Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer.

about

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q55001587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@en

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@nl

type

Item

label

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@en

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@nl

prefLabel

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@en

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@nl

P1476

Feasibility of stereotactic bo ...... ed non-small cell lung cancer.

@en

P2093

Katrina Woodford

http://www.w3.org/2001/XMLSchema#string

Sashendra Senthi

http://www.w3.org/2001/XMLSchema#string

Trieumy Tran Le

http://www.w3.org/2001/XMLSchema#string

Vanessa Panettieri

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Management of clinical stage IIIA primary lung cancers in the National Cancer Database.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer

Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.

Lung cancer in the elderly.

Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer

P304

21-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CTRO.2017.08.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29594219

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5862638

http://www.w3.org/2001/XMLSchema#string